logo
Nvidia and MediaTek rumoured to announce new Windows on Arm laptop chips at Computex 2025

Nvidia and MediaTek rumoured to announce new Windows on Arm laptop chips at Computex 2025

Yahoo09-05-2025

When you buy through links on our articles, Future and its syndication partners may earn a commission.
At the end of last year, I listed a possible Nvidia laptop chip (ie, not just the GPU but the CPU, too) as something I'd really like to see from 2025, and since then we've had plenty of intimations that we might actually see such a thing. Now, we're hearing this might be announced at Computex later this month.
According to ComputerBase (machine translated), "the official unveiling [of an Nvidia PC chip] is now expected at Computex 2025." This wouldn't be a solo venture, though, as it's expected to be made in partnership with MediaTek, based on the Nvidia and MediaTek GB10 chip that sits inside DGX Spark home-user supercomputer (previously called Project Digits).
If it is based on GB10, that would presumably mean a processor using its Arm-designed CPU cores rather than custom Nvidia-designed ones. This wouldn't be a massive surprise, but there was previously at least some reason to believe that it could be using custom-designed chips, given previous rumours and that Nvidia recently announced a custom-designed Arm chip called Vera to succeed its previous Arm-designed Grace chips.
Whether it's custom or Arm-designed, it will be an Arm chip, meaning much will rely on Windows on Arm (WoA). We've seen Arm chips using WoA in the wild over the past year in the form of Qualcomm's Snapdragon X Elite chips that sit inside some laptops. These have great battery life, but there are still some problems with Windows on Arm, especially for gaming. That's mainly thanks to Prism emulation that still struggles with some games.
WoA does seem to be steadily improving, though, and one can only assume Nvidia would have a better time of getting gaming to work than Qualcomm, given the company is already king of the Windows graphics space. Still, there's not a lick that Nvidia can do about Prism emulation itself, so it won't be entirely in the chip giant's hands.
To be clear, that an Nvidia PC chip is in the works isn't all based on rumours: At the start of this year, Nvidia officially confirmed it is working on an end-user system on a chip (SoC) based on DGX Spark.
Now, both Nvidia and MediaTek will be delivering keynotes at Computex on May 19 and 20, respectively, so it makes sense that both companies would use this as a chance to announce an upcoming collaborative consumer SoC.
ComputerBase points out that, according to DigiTimes, MediaTek has booked additional capacity for semiconductor assembly and testing with ASE, implying that this is because of the upcoming laptop chips. Without seeing what this additional capacity is officially booked for, however, we can't say for certain.
We also can't say for certain how such chips will perform. Previous rumours had it that the upcoming SoC should have RTX 4070 mobile and Strix Halo-level performance, and ComputerBase speculates that instead of the 20 CPU cores in the GB10, the laptop chips will likely have "perhaps only eight to twelve, and the RAM [is] likely to be a quarter of that or even less, i.e. 32 or 16 GB—depending on which market segment is ultimately targeted."
Whatever the case, it's certainly an exciting prospect that we could have an Nvidia chip sitting inside some laptops, which would presumably be low-power ones given Arm chips tend to be very efficient. And that they might give us all the benefits of the Blackwell GPU architecture for gaming. And we might not have too long to find out. Roll on Computex.
Best CPU for gaming: Top chips from Intel and AMD.Best gaming motherboard: The right boards.Best graphics card: Your perfect pixel-pusher awaits.Best SSD for gaming: Get into the game first.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Don't Let the Cult of Price Hold Crypto Back
Don't Let the Cult of Price Hold Crypto Back

Yahoo

time17 minutes ago

  • Yahoo

Don't Let the Cult of Price Hold Crypto Back

Cryptocurrency is too often viewed through the narrow lens of price. The dominant narrative surrounding Bitcoin, Ethereum, and the broader crypto market has become fixated on one idea: numbers go up. Did Bitcoin break $100,000? Did Ethereum double in a month? Is this altcoin going to the moon? Financial media, X pundits, and even crypto advocates routinely reduce an entire technological revolution to a speculative race to ever-higher prices. But this is like evaluating Apple or Nvidia solely by their stock movements while ignoring the iPhone or the GPUs powering AI infrastructure. It's a superficial way of thinking — and in crypto, it's also dangerous. In traditional markets, value is ultimately grounded in usage. The more products a company sells, the more revenue it generates. The more users it retains, the stronger its network effect. Apple isn't a $3 trillion company just because its stock price went up; it's because over a billion people use its ecosystem daily. Nvidia didn't become a Wall Street darling by sheer momentum; it built the most essential chips of the AI age. Stock price follows product-market fit. In crypto, this principle is often inverted — price comes first, and everything else becomes secondary or is this philosophy more deeply ingrained than in what might be called Saylorism — the ideology promoted by MicroStrategy's Michael Saylor, the loudest evangelist for Bitcoin-as-collateral. Under this worldview, the core utility of Bitcoin isn't transacting, building, or innovating — it's simply holding. You buy Bitcoin, never sell, borrow against it, repeat. The usage is the hoarding. Bitcoin is not a currency or platform under Saylorism — it's a speculative vault for value, designed to appreciate forever and justify more borrowing. In essence, every company becomes a leveraged Bitcoin fund, building its capital structure around a single bet: that the number always goes up. This is a radical departure from the logic that underpins healthy businesses. Traditional firms grow by creating value for others, through products, services, and infrastructure. Under Saylorism, value is internalized, circular, and ultimately recursive: you buy more Bitcoin because it's going up, which makes it go up, which justifies buying more. It resembles a corporate Ponzi mindset, not in legal terms, but in structural dynamics, where external adoption matters less than internal leverage. The market doesn't need new users, it just needs existing holders to keep believing. Compare that to Ethereum, the second-largest cryptocurrency by market cap, which has taken a different path. While Ethereum is also subject to the gravitational pull of price speculation, and no one would argue that 'number goes up' doesn't matter; its value proposition is fundamentally rooted in usage. ETH is not just a store of value; it is the fuel of an economy. It powers decentralized applications, settles billions in stablecoin transactions, tokenizes real-world assets, mints NFTs, facilitates decentralized finance, and supports governance. ETH has demand because the network has demand. The more people use Ethereum, the more ETH is needed. And the more ETH is burned through transaction fees, the more supply becomes constrained. Price here reflects activity, not just belief. This distinction is profound. Ethereum's growth is tied to its functionality, to what it enables for users and developers. It resembles a traditional business more than a vault. It's like Amazon in the early 2000s: difficult to value by conventional metrics but serving a growing ecosystem. The difference between these two models–Bitcoin as gold and Ethereum as infrastructure–has sparked endless debate over whether they're even in competition. Some argue they're entirely different species: Bitcoin is a monetary metal; Ethereum is a decentralized world computer, perhaps likened to digital oil. It's fair to ask: what's ultimately more valuable, the gold you keep or the dollar you spend? Bitcoin's value depends on people holding it. Ethereum's value depends on people using it. Both are succeeding, but the paths are not the same. If cryptocurrency is to evolve beyond its speculative adolescence, it must shift away from price obsession and toward utility obsession. This means asking harder questions: What is this protocol used for? Who depends on it? What problem does it solve? Valuation must come from participation, not just price action. A blockchain that delivers real-world utility for finance, identity, coordination, or computation deserves appreciation. But it must earn it through adoption, not ideology. What if, instead of competing, Bitcoin and Ethereum found common ground and worked together? That's where the opportunity emerges: Ethereum serves as the most robust gateway for Bitcoin holders looking to access the broader world of decentralized finance. No network rivals Ethereum in terms of DeFi's depth and maturity. By converting BTC into Ethereum-compatible assets, holders can engage in a dynamic ecosystem of lending, staking, and yield generation, turning dormant Bitcoin into active, value-producing capital. Platforms like Aave, Lido, Ethena, and Maker enable BTC to participate in ways that static holding simply can't. The outcome? Mutual benefit: Ethereum attracts more liquidity, while Bitcoin gains much-needed utility. It's a powerful synergy that amplifies the strengths of both networks. Cryptocurrency is not just a dumb financial asset It's programmable money, digital property, frictionless transactions, decentralized coordination, and trustless finance. It's a reimagining of the internet's economic layer. But its long-term success depends on moving past the dopamine of daily price charts. Because in the end, the most valuable technologies aren't the ones with the flashiest tickers; they're the ones that get used. And usage, not hoarding, is what builds lasting in to access your portfolio

BlackRock portfolio managers 'laser focused' on capturing market opportunities
BlackRock portfolio managers 'laser focused' on capturing market opportunities

Yahoo

time27 minutes ago

  • Yahoo

BlackRock portfolio managers 'laser focused' on capturing market opportunities

-- BlackRock analysts said in a note this week that their portfolio managers are "laser focused on how and where to capture opportunities, even as uncertainty abounds" and policymaking continues to disrupt markets. The firm revealed that this was a key takeaway from their recent internal Midyear Forum. U.S. stocks saw a rise last week following news of renewed U.S.-China trade talks and a strong U.S. jobs report. However, BlackRock (NYSE:BLK) notes it's "too soon to tell if tariffs are hurting the labor market." The firm is closely watching U.S. CPI data to determine if tariffs are contributing to inflation, with concerns that "persistent inflation pressure limit[s] how far the Fed can cut rates this year." BlackRock emphasizes that policymaking has become a source of disruption, not stability, with stickier inflation and swelling public debt in the U.S. This has led to reduced room for maneuver for governments and central banks, making the "macro outlook less predictable." Despite this volatility, BlackRock's managers are finding opportunities by "looking through the near-term noise and focusing on the big picture." They agreed that the drivers of top-performing companies' equity gains "have not actually changed much." Among the opportunities, there is a "shared conviction in the AI mega force driving further returns," with Nvidia (NASDAQ:NVDA)'s recent earnings beat cited as an example, despite tariff-related drags. However, they also noted "medium-term regulatory risk and the potential for slower deployment." Energy is another favored sector, with AI driving global energy demand and governments prioritizing "homegrown, reliable power." Related articles BlackRock portfolio managers 'laser focused' on capturing market opportunities Snap to launch consumer smart glasses in 2025, rivaling Meta Bitcoin winter not coming back, says Strategy's Saylor Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Backing the Future of Global Biotech: Reynold Lemkins' Strategy Across Borders and Stages
Backing the Future of Global Biotech: Reynold Lemkins' Strategy Across Borders and Stages

Business Wire

time32 minutes ago

  • Business Wire

Backing the Future of Global Biotech: Reynold Lemkins' Strategy Across Borders and Stages

HONG KONG--(BUSINESS WIRE)-- Reynold Lemkins Group, an international investment firm focused on value-driven cross-border capital deployment, announced the continued advancement of its strategic focus in late-stage healthcare, AI-powered therapeutics, and Asia-centered biotech commercialization. Bridging East and West in biotech investing, Reynold Lemkins backs science-driven companies with cross-border capital and global scale strategies. Share As part of this strategy, Reynold Lemkins recently participated in the IPO of VISEN Pharmaceuticals on the Hong Kong Stock Exchange (HKEX: 02561). VISEN, a biopharmaceutical company specializing in long-acting growth hormone therapies, attracted strong institutional demand and represents the kind of regulatory-validated, commercially scalable business the firm targets. Reynold Lemkins invested alongside globally recognized healthcare investors including HongShan Capital Group (previously Sequoia China), Sofinnova, Vivo Capital, OrbiMed, and WuXi Biologics (HKEX: 2269), reinforcing its commitment to cross-border innovation and long-term capital alignment. This investment underscores Reynold Lemkins' broader strategy of supporting science-driven, late-stage companies with scalable market potential—particularly those operating at the convergence of AI, therapeutics, and Asia-Pacific commercialization. 'Our approach focuses on more than capital—we provide strategic insight and cross-border connectivity to help companies scale,' said Kris Haoran Liu, President and Chief Investment Officer at Reynold Lemkins Group. 'Biotech firms entering public markets need partners who understand both the science and the structure of global growth.' With Asia playing an increasingly pivotal role in global healthcare, Reynold Lemkins sees a growing need for capital strategies that link scientific innovation with scalable regional execution. At the same time, the firm closely tracks trends in the U.S. and other mature markets, where biotech companies are navigating longer paths to liquidity and require strategic partners with global reach. Reynold Lemkins positions itself at this intersection—bridging East and West, public and private markets—to support companies shaping the next era of patient-centered care. To learn more, visit follow us on LinkedIn, or explore our insights on Medium.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store